1 in 4 cancer patients eligible for life-saving immunotherapy is missed due to faulty diagnosis
Oncology
Regulatory-grade synthetic patients accelerating clinical trials with AI
Precision Oncology and to create Responder in Cancer Treatment
Accelerating life-saving therapies with generative AI-native in silico drug & vaccine discovery.
Developing a first-in-class nano carrier with intrinsic antitumoral activity.
Unlocking solid tumors with first-in-class pre-T cell therapies
Highlighting the unseen with molecular clarity so surgeons leave no cancer behind.
Single Molecule Detection Transforming Next-Gen Sequencing & Diagnostic Testing










